UNSPSC 51391605: Milrinone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H9N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JU9YAX04C7, chemically known as 1,6-dihydro-2-methyl-6-oxo-(3,4-bipyridine)-5-carbonitrile but generally known as milrinone, which bears US NIH Compound Identifier 4197. European Medicines Agency schedules Milrinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08968MIG.

UNSPSC 51391605 Milrinone is a Commodity code that in recent state and local procurement activity covers pharmaceutical and medical supply procurement, though the recent opportunities block shows a mismatch between the code's nominal scope and actual solicitation content. Seminole County, Florida's posted opportunity (IFB60459723LAS, due Jul 26, 2023) sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—opioid-reversal and harm-reduction supplies rather than milrinone, a cardiac inotropic agent. The solicitation called for quarterly deliveries to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping and delivery costs included in bids. Bidders were required to submit unit costs for each line item, maintain drug-free workplace certification and E-Verify compliance, carry workers' compensation and commercial general liability insurance, and accept a three-month probationary termination clause. The contract was structured as a two-year initial term with one-year renewal option, potentially funded through FEMA, which triggered additional compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.

The single recent opportunity identified in the source originates from a Florida county health department, and geographic spread beyond that posting cannot be determined from available records. The code shows limited recent activity; if the Seminole County opportunity represents the current state of procurement under UNSPSC 51391605, the code's actual use in state and local purchasing diverges substantially from its nominal pharmaceutical scope and may warrant reclassification or clarification with the procurement office before committing resources to pursue similar opportunities.